Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Beta-catenin expression in Dupuytren's disease: potential role for cell–matrix interactions in modulating beta-catenin levels in vivo and in vitro

Abstract

Dupuytren's disease (DD) is a superficial fibromatosis of the hand. Although the molecular mechanisms responsible for this disease are unknown, recent studies suggest that beta-catenin may be a key factor involved in fibromatosis. In this study, we analysed the in vivo and in vitro expression levels of beta-catenin in DD, using surgical specimens and primary cell lines. Although no somatic mutations (exon 3) of beta-catenin were detected, Western blot analysis revealed high levels of beta-catenin in diseased palmar fascia, and low to undetectable levels of beta-catenin in patient-matched normal palmar fascia. Immunohistochemistry analysis showed high levels of beta-catenin expression within the disease fascia, as well as cytoplasmic and nuclear accumulations of the protein. Immunoprecipitation of beta-catenin from seven patient lesions showed the protein to be tyrosine phosphorylated. Lastly, Western analysis of three patient-matched (disease and normal fascia) primary cell cultures showed significantly elevated levels of beta-catenin in disease cells cultured in three-dimensional collagen lattices. This is the first extensive in vivo and in vitro characterization of beta-catenin in DD, and the first to suggest that the extracellular matrix may play an important role in modulating beta-catenin stability in DD.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Abraham SC, Reynolds C, Lee JH, Montgomery EA, Baisden BL, Krasinskas AM and Wu TT . (2002). Hum. Pathol., 33, 39–46.

  • An HS, Southworth SR, Jackson WT and Russ B . (1988). J. Hand Surg. Am., 13, 872–874.

  • Arafa M, Noble J, Royle SG, Trail IA and Allen J . (1992). J. Hand Surg. Br., 17, 221–224.

  • Behrens J, Vakaet L, Friis R, Winterhager E, Van Roy F, Mareel MM and Birchmeier W . (1993). J. Cell. Biol., 120, 757–766.

  • Bonnici AV, Birjandi F, Spencer JD, Fox SP and Berry AC . (1992). J. Hand Surg. Br., 17, 349–355.

  • Boudreau N and Bissell MJ . (1998). Curr. Opin. Cell. Biol., 10, 640–646.

  • Burge P . (1999). Hand Clin., 15, 63–71.

  • Burge P, Hoy G, Regan P and Milne R . (1997). J. Bone Joint Surg. Br., 79, 206–210.

  • Cadigan KM and Nusse R . (1997). Genes Dev., 11, 3286–3305.

  • Cheon SS, Cheah AY, Turley S, Nadesan P, Poon R, Clevers H and Alman BA . (2002). Proc. Natl. Acad. Sci. USA, 30, 30.

  • Dal Cin P, De Smet L, Sciot R, Van Damme B and Van den Berghe H . (1999). Cancer Genet. Cytogenet., 108, 137–140.

  • De Wever I, Dal Cin P, Fletcher CD, Mandahl N, Mertens F, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, Van Den Berghe H, Vanni R and Willen H . (2000). Mod. Pathol., 13, 1080–1085.

  • Dupuytren G . (1834). Lancet, 2, 222–225.

  • Gradl D, Kuhl M and Wedlich D . (1999). Mol. Cell. Biol., 19, 5576–5587.

  • Gudmundsson KG, Arngrimsson R, Sigfusson N and Jonsson T . (2002). J. Clin. Epidemiol., 55, 5–10.

  • Hanai J, Dhanabal M, Karumanchi SA, Albanese C, Waterman M, Chan B, Ramchandran R, Pestell R and Sukhatme VP . (2002a). J. Biol. Chem., 277, 16464–16469.

  • Hanai J, Gloy J, Karumanchi SA, Kale S, Tang J, Hu G, Chan B, Ramchandran R, Jha V, Sukhatme VP and Sokol S . (2002b). J. Cell. Biol., 158, 529–539.

  • Hart M, Concordet JP, Lassot I, Albert I, del los Santos R, Durand H, Perret C, Rubinfeld B, Margottin F, Benarous R and Polakis P . (1999). Curr. Biol., 9, 207–210.

  • Kloen P . (1999). Br. J. Plast. Surg., 52, 629–635.

  • Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B and Clevers H . (1997). Science, 275, 1784–1787.

  • Kuhn MA, Wang X, Payne WG, Ko F and Robson MC . (2002). J. Surg. Res., 103, 146–152.

  • Latres E, Chiaur DS and Pagano M . (1999). Oncogene, 18, 849–854.

  • McFarlane RM . (1991). J. Hand Surg. Am., 16, 775–779.

  • Mikkelsen OA . (1978). Hand, 10, 1–8.

  • Mikkelsen OA, Hoyeraal HM and Sandvik L . (1999). J. Hand Surg. Br., 24, 515–518.

  • Montgomery E, Lee JH, Abraham SC and Wu TT . (2001). Mod. Pathol., 14, 695–701.

  • Morin PJ . (1999). Bioessays, 21, 1021–1030.

  • Muller T, Choidas A, Reichmann E and Ullrich A . (1999). J. Biol. Chem., 274, 10173–10183.

  • Noble J, Arafa M, Royle SG, McGeorge G and Crank S . (1992). J. Hand Surg. Br., 17, 71–74.

  • Noble J, Heathcote JG and Cohen H . (1984). J. Bone Joint Surg. Br., 66, 322–325.

  • Polakis P . (2000). Genes Dev., 14, 1837–1851.

  • Rayan GM . (1999). Hand Clin., 15, 87–96, vii.

  • Ross DC . (1999). Hand Clin., 15, 53–62, vi.

  • Schwartz MA and Ginsberg MH . (2002). Nat. Cell Biol., 4, E65–E68.

  • Sergovich FR, Botz JS and McFarlane RM . (1983). N. Engl. J. Med., 308, 162–163.

  • Shibamoto S, Hayakawa M, Takeuchi K, Hori T, Oku N, Miyazawa K, Kitamura N, Takeichi M and Ito F . (1994). Cell Adhes. Commun., 1, 295–305.

  • Shibata T, Ochiai A, Kanai Y, Akimoto S, Gotoh M, Yasui N, Machinami R and Hirohashi S . (1996). Oncogene, 13, 883–889.

  • Shimizu H, Julius MA, Giarre M, Zheng Z, Brown AM and Kitajewski J . (1997). Cell Growth Differ., 8, 1349–1358.

  • Skoog T . (1960). Plastic Reconstr. Surg., 31, 258–263.

  • Tejpar S, Nollet F, Li C, Wunder JS, Michils G, dal Cin P, Van Cutsem E, Bapat B, van Roy F, Cassiman JJ and Alman BA . (1999). Oncogene, 18, 6615–6620.

  • Wang H and Chakrabarty S . (2001). J. Cell Physiol., 187, 188–195.

  • Winston JT, Strack P, Beer-Romero P, Chu CY, Elledge SJ and Harper JW . (1999). Genes Dev., 13, 270–283.

  • Wurster-Hill DH, Brown F, Park JP and Gibson SH . (1988). Am. J. Hum. Genet., 43, 285–292.

Download references

Acknowledgements

We thank Roy Taylor and Jeanette Botz from the tissue bank (Department of Pathology, London Health Science Centre) for the paraffin sectioning and immunohistochemistry work. This study is supported by grants from the Plastic Surgery Education Fund (BSG, JCH), Canadian Orthopaedic Foundation (JCH, BSG, DCR, JHR, RMM), American Society for Surgery of the Hand (DCR, JCH, RMM, BSG), and the Lawson Health Research Institute's Internal Research Fund (JCH, BSG).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jeffrey C Howard.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Varallo, V., Gan, B., Seney, S. et al. Beta-catenin expression in Dupuytren's disease: potential role for cell–matrix interactions in modulating beta-catenin levels in vivo and in vitro. Oncogene 22, 3680–3684 (2003). https://doi.org/10.1038/sj.onc.1206415

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206415

Keywords

This article is cited by

Search

Quick links